Study to Evaluate the Safety and Immunogenicity of Nimenrix (Registered) in Healthy Infants, Given at 3 and 12 Months of Age

Exclusion Criteria

• •Previous anaphylactic reaction to any vaccine or vaccine-related component.
• •Bleeding diathesis or condition associated with prolonged bleeding time that would contraindicate intramuscular injection.
• •History of microbiologically proven disease caused by N meningitidis or Neisseria gonorrhoeae.
• •Significant neurological disorder or history of seizure (including simple febrile seizure).
• •Any confirmed or suspected immunosuppressive or immunodeficient condition, based on medical history and physical examination (no laboratory testing required).
• •Family history of congenital or hereditary immunodeficiency.
• •Other medical or psychiatric condition, including recent or active suicidal ideation/behavior, or laboratory abnormality that may increase the risk of study participation or, in the investigator's judgment, make the participant inappropriate for the study.
• •Major known congenital malformation or serious chronic disorder.
• •Previous vaccination with any meningococcal vaccine containing groups A, C, W, or Y.